Karin Rosén moves on from GSK, now playing dual roles at Horizon; Gilead looks to Jared Baeten to take command of HIV strategy

Karin Rosén

→ GSK and Genentech alum Karin Rosén is expanding her horizons, so to speak, taking on the roles of CSO and EVP, R&D at Horizon Therapeutics. Rosén departs for Horizon from her gig at GSK as SVP of US medical affairs, and she was a…

Click to view original post